NiaVasc™ 750 120 Tablets

High-Dose Extended-Release Niacin Supplement 750mg for Lipid Management and Cardiovascular Health

NiaVasc 750 120 Tablets by XYMOGEN is a high-potency extended-release niacin supplement delivering 750mg per tablet in a 120-tablet supply. At this therapeutic dose, niacin has the most robust lipid-modifying effects — raising HDL, lowering triglycerides, and shifting LDL particle size — making it one of the most effective natural tools for comprehensive lipid panel improvement.

Why 750mg Niacin Produces Meaningful Lipid Effects

Research on niacin's lipid-modifying effects is dose-dependent. At lower doses (100–250mg), niacin has minimal impact on lipids. At 750mg and above, the effects on HDL elevation (often 15–30%), triglyceride reduction, and LDL particle size shift become clinically significant. The extended-release matrix at this dose provides therapeutic lipid benefits with meaningfully reduced flushing compared to immediate-release.

Key Features of This High-Dose Niacin Supplement

• 750mg extended-release niacin per tablet — therapeutic lipid-modifying dose
• Supports HDL elevation, triglyceride reduction, and LDL optimization
• 120 tablets — 30-60 day supply depending on dose
• Extended-release matrix for reduced flushing at high dose
• For use under practitioner guidance in lipid management protocols

Who This Is For

This high-dose niacin supplement is best suited for adults working with a practitioner on significant lipid panel optimization — particularly those with low HDL, elevated triglycerides, or small dense LDL patterns requiring therapeutic-dose niacin intervention.

How to Use

Take as directed by your healthcare provider. Therapeutic niacin requires medical supervision.